LEXINGTON, Mass.--(BUSINESS WIRE)--March 6, 2006--Critical Therapeutics, Inc. (Nasdaq: CRTX) today announced that two scientific posters on ZYFLO(R) (zileuton tablets) were presented at the American Academy of Allergy, Asthma & Immunology (AAAAI) 2006 Annual Meeting in Miami Beach, Florida.
